Type(s) of biological/targeted therapy-Carfilzomib Posts on Medivizor
Navigation Menu

Type(s) of biological/targeted therapy-Carfilzomib Posts on Medivizor

Comparing the outcomes of carfilzomib once-weekly vs twice-weely in patients with relapsed/refractory multiple myeloma

Comparing the outcomes of carfilzomib once-weekly vs twice-weely in patients with relapsed/refractory multiple myeloma

Posted by on Oct 29, 2020 in Multiple Myeloma | 0 comments

In a nutshell The study compared outcomes of once-weekly (OW) versus twice-weekly (TW) carfilzomib (Kyprolis) plus dexamethasone (Decadron) in Japanese patients with relapsed/refractory (RR) multiple myeloma (MM). The authors found that the OW dosage improved overall response rate (ORR) compared to TW in such patients. Some background RR-MM...

Read More

Looking for patients with relapsed multiple myeloma to test a biological drug and immune cell vaccine

Posted by on Jul 31, 2019 in Multiple Myeloma | 0 comments

In a nutshell This trial is investigating the effectiveness and side effects of nivolumab (Opdivo) with a dendritic cell vaccine for patients with multiple myeloma (MM). The main outcome of this study would be to see the number of patients that develop an allergic reaction to the treatment. This study is recruiting in Boston, MA, United...

Read More